Worsening of quality of life (QoL), cognitive functions (CF) and psychological status (PSY) can predict radiologic progressive disease (RPD) in glioblastoma (GBM) patients (PTS) treated with radiation therapy (RT) and temozolomide (TMZ): a mono-institutional prospective study

Authors :: Giuseppe Lombardi
L. Bellu
S. Dal Pos
P. Del Bianco
E. Bergo
Ardi Pambuku
Vittorina Zagonel
F. Berti
Source :: Annals of Oncology. 28:vi76
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Temozolomide
business.industry
medicine.medical_treatment
Cognition
Hematology
medicine.disease
Radiation therapy
Psychological status
Quality of life
Internal medicine
Physical therapy
Medicine
business
Prospective cohort study
Progressive disease
Glioblastoma
medicine.drug

Full Text Access

Tools